Dennis D. Kim - Mar 28, 2023 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
Chief Medical Officer
Signature
/s/ Paul Quinlan, as attorney-in-fact for Dennis D. Kim
Stock symbol
CBAY
Transactions as of
Mar 28, 2023
Transactions value $
-$462
Form type
4
Date filed
3/30/2023, 05:39 PM
Previous filing
Jan 27, 2023
Next filing
Apr 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBAY Common Stock Options Exercise $437 +100 +0.5% $4.37 20.1K Mar 28, 2023 Direct
transaction CBAY Common Stock Sale -$899 -100 -0.5% $8.99 20K Mar 28, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -100 -0.03% $0.00 290K Mar 28, 2023 Common Stock 100 $4.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.